Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in the presence of CD4-mimetics

• Published in: Journal of virology 2024-09, Vol.98 (10), p.e0096024
• Main Authors: Tauzin, Alexandra, Marchitto, Lorie, Bélanger, Étienne, Benlarbi, Mehdi, Beaudoin-Bussières, Guillaume, Prévost, Jérémie, Yang, Derek, Chiu, Ta-Jung, Chen, Hung-Ching, Bourassa, Catherine, Medjahed, Halima, Korzeniowski, Marek K, Gottumukkala, Suneetha, Tolbert, William D, Richard, Jonathan, Smith, 3rd, Amos B, Pazgier, Marzena, Finzi, Andrés
• Format: Article
• Language: English
• Subjects: Pathogenesis and Immunity; Virology
• ISSN: 0022-538X; 1098-5514; 1098-5514
• DOI: 10.1128/jvi.00960-24

CD4-mimetics (CD4mcs) are small molecule compounds that mimic the interaction of the CD4 receptor with HIV-1 envelope glycoproteins (Env). Env from primary viruses normally samples a "closed" conformation that occludes epitopes recognized by CD4-induced (CD4i) non-neutralizing antibodies (nnAbs). CD4mcs induce conformational changes on Env resulting in the exposure of these otherwise inaccessible epitopes. Here, we evaluated the capacity of plasma from a cohort of 50 people living with HIV to recognize HIV-1-infected cells and eliminate them by antibody-dependent cellular cytotoxicity (ADCC) in the presence of a potent indoline CD4mc. We observed a marked heterogeneity among plasma samples. By measuring the levels of different families of CD4i Abs, we found that the levels of anti-cluster A, anti-coreceptor binding site, and anti-gp41 cluster I antibodies are responsible for plasma-mediated ADCC in the presence of CD4mc. There are several reasons that make it difficult to target the HIV reservoir. One of them is the capacity of infected cells to prevent the recognition of HIV-1 envelope glycoproteins (Env) by commonly elicited antibodies in people living with HIV. Small CD4-mimetic compounds expose otherwise occluded Env epitopes, thus enabling their recognition by non-neutralizing antibodies (nnAbs). A better understanding of the contribution of these antibodies to eliminate infected cells in the presence of CD4mc could lead to the development of therapeutic cure strategies.